In this grant, attempts will be made to identify a putative arthritogenic epitope of B. burgdorferi using molecular biologic techniques to map T and B cell epitopes of the spirochete. The postulate is that in patients who are genetically susceptible to chronic Lyme arthritis, one antigenic fragment of B. burgdorferi combines with a distinct conformation encoded by the DR4 haplotype. Preliminary work suggests that this epitope may be located on the OspA or B proteins. The interaction of this MHC-peptide complex with CD4-positive T cells may trigger an untoward immune response with autoreactive features leading to chronic arthritis. In an effort to identify such an epitope, fusion proteins will be generated in an E. coli expression vector using restriction fragments of the 49 kb plasmid encoding for the OspA and B proteins. To begin the process of mapping B cell epitopes, the fusion proteins will be tested in an ELISA for their reactivity with the sera of DR4-positive of negative patients who have the antibody responses associated with either brief or chronic Lyme arthritis. To begin the process of T cell mapping, the fusion proteins will be tested in a proliferative assay for their reactivity with peripheral blood and/or synovial fluid lymphocytes from the same groups of patients. B. burgdorferi-reactive T cell clones will be generated and those that react with the OspA and B proteins and with the fusion proteins will be identified. The sequences of the immunoreactive fusion proteins will be deduced from the known sequences of the OSPA and B proteins, and overlapping synthetic peptides will be made and tested against patients' sera and cells in an effort to identify the putative arthritogenic peptide sequence. This work is likely to influence the treatment of patients with chronic Lyme arthritis; it will provide guidelines for mapping other T and B cell epitopes of B. burgdorferi, and it may have implications for vaccine development since immunity to the Osp proteins may play a role in protection, but may also trigger an autoimmune response in genetically susceptible individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR040576-01
Application #
3160995
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1990-03-01
Project End
1993-02-28
Budget Start
1990-03-01
Budget End
1991-02-28
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Steere, A C; Levin, R E; Molloy, P J et al. (1994) Treatment of Lyme arthritis. Arthritis Rheum 37:878-88
Nocton, J J; Dressler, F; Rutledge, B J et al. (1994) Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330:229-34
Fung, B P; McHugh, G L; Leong, J M et al. (1994) Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect Immun 62:3213-21
Lengl-Janssen, B; Strauss, A F; Steere, A C et al. (1994) The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med 180:2069-78
Dressler, F; Ackermann, R; Steere, A C (1994) Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis 169:313-8
Dressler, F; Whalen, J A; Reinhardt, B N et al. (1993) Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167:392-400
Kalish, R A; Leong, J M; Steere, A C (1993) Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 61:2774-9
Axford, J S; Watts, R A; Long, A A et al. (1993) Expression of public idiotypes in patients with Lyme arthritis. Ann Rheum Dis 52:199-205
Miller, L C; Isa, S; Vannier, E et al. (1992) Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest 90:906-12
Steere, A C (1991) Clinical definitions and differential diagnosis of Lyme arthritis. Scand J Infect Dis Suppl 77:51-4

Showing the most recent 10 out of 11 publications